Douglas D Richman1. 1. VA San Diego Healthcare System, Department of Pathology, Center for AIDS Research, University of California, San Diego, California, USA. drichman@ucsd.edu
Abstract
PURPOSE OF REVIEW: Renewed interest has emerged to address the latent reservoir of HIV to achieve a cure. RECENT FINDINGS: The integrated proviral genome is a fundamental component of the retroviral replication cycle. The establishment of latently infected CD4+ lymphocytes, and perhaps other as yet poorly characterized cells, represents a reservoir of HIV infection that is not appreciably affected by effective antiretroviral chemotherapy. Effective management of HIV infection, thus, will require lifelong treatment unless an approach to purging this reservoir is identified. Although substantial insights about the latent reservoir have been made, our understanding about the details of the reservoirs, the mechanisms of latency and potential targets to eliminate latently infected cells is too primitive to achieve a cure without a great deal of basic research to elucidate some of these areas. SUMMARY: A resurgence of interest in latent infection and its treatment promises progress in addressing the challenge of a cure, although, realistically, this will require a prolonged period of investigation in many areas.
PURPOSE OF REVIEW: Renewed interest has emerged to address the latent reservoir of HIV to achieve a cure. RECENT FINDINGS: The integrated proviral genome is a fundamental component of the retroviral replication cycle. The establishment of latently infected CD4+ lymphocytes, and perhaps other as yet poorly characterized cells, represents a reservoir of HIV infection that is not appreciably affected by effective antiretroviral chemotherapy. Effective management of HIV infection, thus, will require lifelong treatment unless an approach to purging this reservoir is identified. Although substantial insights about the latent reservoir have been made, our understanding about the details of the reservoirs, the mechanisms of latency and potential targets to eliminate latently infected cells is too primitive to achieve a cure without a great deal of basic research to elucidate some of these areas. SUMMARY: A resurgence of interest in latent infection and its treatment promises progress in addressing the challenge of a cure, although, realistically, this will require a prolonged period of investigation in many areas.
Authors: M Hermankova; S C Ray; C Ruff; M Powell-Davis; R Ingersoll; R T D'Aquila; T C Quinn; J D Siliciano; R F Siliciano; D Persaud Journal: JAMA Date: 2001-07-11 Impact factor: 56.272
Authors: Michael W Melkus; Jacob D Estes; Angela Padgett-Thomas; Joel Gatlin; Paul W Denton; Florence A Othieno; Anja K Wege; Ashley T Haase; J Victor Garcia Journal: Nat Med Date: 2006-10-22 Impact factor: 53.440
Authors: Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz Journal: Science Date: 2009-03-06 Impact factor: 47.728
Authors: T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano Journal: Nature Date: 1997-05-08 Impact factor: 49.962
Authors: Justin R Bailey; Ahmad R Sedaghat; Tara Kieffer; Timothy Brennan; Patricia K Lee; Megan Wind-Rotolo; Christine M Haggerty; Ashrit R Kamireddi; Yi Liu; Jessica Lee; Deborah Persaud; Joel E Gallant; Joseph Cofrancesco; Thomas C Quinn; Claus O Wilke; Stuart C Ray; Janet D Siliciano; Richard E Nettles; Robert F Siliciano Journal: J Virol Date: 2006-07 Impact factor: 5.103
Authors: Anding Shen; Hung-Chih Yang; Yan Zhou; Amanda J Chase; Jean D Boyer; Hao Zhang; Joseph B Margolick; M Christine Zink; Janice E Clements; Robert F Siliciano Journal: J Virol Date: 2006-12-06 Impact factor: 5.103
Authors: Tara L Kieffer; Mariel M Finucane; Richard E Nettles; Thomas C Quinn; Karl W Broman; Stuart C Ray; Deborah Persaud; Robert F Siliciano Journal: J Infect Dis Date: 2004-04-05 Impact factor: 5.226
Authors: Christoph C Carter; Adewunmi Onafuwa-Nuga; Lucy A McNamara; James Riddell; Dale Bixby; Michael R Savona; Kathleen L Collins Journal: Nat Med Date: 2010-03-07 Impact factor: 53.440
Authors: Deborah Persaud; George K Siberry; Aima Ahonkhai; Joleen Kajdas; Daphne Monie; Nancy Hutton; Douglas C Watson; Thomas C Quinn; Stuart C Ray; Robert F Siliciano Journal: J Virol Date: 2004-01 Impact factor: 5.103
Authors: Mariela Bollini; Ricardo Gallardo-Macias; Krasimir A Spasov; Julian Tirado-Rives; Karen S Anderson; William L Jorgensen Journal: Bioorg Med Chem Lett Date: 2012-12-12 Impact factor: 2.823
Authors: Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia Journal: J Virol Date: 2011-10-19 Impact factor: 5.103
Authors: Will Dampier; Michael R Nonnemacher; Joshua Mell; Joshua Earl; Garth D Ehrlich; Vanessa Pirrone; Benjamas Aiamkitsumrit; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Jeffrey M Jacobson; Brian Wigdahl Journal: PLoS One Date: 2016-05-19 Impact factor: 3.240